Potential link found between Merck antiviral and mutated COVID strains ...Middle East

The Hill - News
Potential link found between Merck antiviral and mutated COVID strains
A new study published Monday links COVID-19 antiviral created by Merck with new mutations of the virus that have been sequenced around the world. Molnupiravir, known commercially as Lagevrio, is one of two COVID-19 antivirals authorized for treating coronavirus infections along with Paxlovid from Pfizer. The drug works by inducing mutations in the virus's cells as it replicates, resulting in random mutations that are harmful to the virus and cuts down on its viral load. Researchers from the U.K. and South African delved into the question of where some mutated variants may have occurred, given that some have been found with seemingly random mutations, and whether molnupiravir may hav

Hence then, the article about potential link found between merck antiviral and mutated covid strains was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Potential link found between Merck antiviral and mutated COVID strains )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News